14. Providing more answers for patients with supplemental RNA analysis

To help resolve the clinical significance of variants predicted to alter splicing, and identify splice-altering variants in regions outside of the reportable range of our routine hereditary cancer DNA sequencing tests, we initiated an IRB-approved RNA-sequencing research study at Invitae.

Source: Cancer Genetics and Cytogenetics - November 1, 2022 Category: Genetics & Stem Cells Authors: Laure Fresard, Keith Nykamp, Nick Kamp-Hughes, John Vincent, Sarah Albritton, Victoria Carlton, Hio Chung Kang, Kate Krempely, Carolina Pardo Source Type: research